Insight into the regulatory mechanism of m6A modification: From MAFLD to hepatocellular carcinoma

Xuan Zha1, Zewei Gao2, Min Li2

  • 1Department of Laboratory Medicine, the Affiliated Hospital of Jiangsu University, Zhenjiang, China; Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.

Insights

Metabolic-associated fatty liver disease (MAFLD) is rising globally. This review explores how N6-methyladenosine (m6A) modification impacts MAFLD progression to liver cancer and its therapeutic potential.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Oncology

Background:

  • Metabolic-associated fatty liver disease (MAFLD) incidence is increasing globally, linked to obesity and type 2 diabetes mellitus (T2DM).
  • MAFLD affects over one-third of adults worldwide, becoming the most common liver disease.
  • MAFLD is a significant risk factor for hepatocellular carcinoma (HCC), with a notable percentage of HCC cases arising directly from MAFLD without cirrhosis.

Purpose of the Study:

  • To investigate the role of N6-methyladenosine (m6A) modification in the progression of MAFLD to HCC.
  • To explore the potential of targeting m6A as a therapeutic strategy for MAFLD-related HCC.
  • To identify future research directions concerning m6A in MAFLD-HCC transition.

Main Methods:

  • Review of existing literature on m6A modification, MAFLD, and HCC.
  • Analysis of studies linking aberrant m6A patterns to metabolic alterations and cancer development.
  • Synthesis of current understanding regarding m6A's impact on MAFLD pathogenesis and HCC transformation.

Main Results:

  • Abnormal m6A modification is closely associated with cellular metabolic dysregulation, contributing to MAFLD onset and progression.
  • Evidence suggests a critical role for m6A in the direct transformation of MAFLD to HCC.
  • The precise mechanisms by which m6A influences MAFLD-to-HCC transition require further elucidation.

Conclusions:

  • Aberrant m6A modification is implicated in the progression of MAFLD to HCC.
  • Targeting m6A pathways presents a promising therapeutic avenue for MAFLD-related HCC.
  • Further research is warranted to fully understand and exploit m6A's role in MAFLD-associated liver cancer.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
889
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.7K